Literature DB >> 1848687

Multiple sclerosis, retroviruses, and PCR. The HTLV-MS Working Group.

G D Ehrlich1, J B Glaser, V Bryz-Gornia, J Maese, T A Waldmann, B J Poiesz, S J Greenberg.   

Abstract

Previously reported serologic and polymerase chain reaction (PCR)-based findings have suggested an association between the human retrovirus, HTLV-I, and multiple sclerosis (MS). Due to the inherent ability of PCR to produce false-positive results, we developed a set of physical and procedural safeguards to minimize the possibility of molecular carryover. These were applied as part of a blinded, large-scale, multipopulation, multiplex PCR-based study designed to examine this issue of association. Our results do not support the hypothesis that HTLV-I, which plays a role in the pathogenesis of an encephalomyeloneuropathy, HTLV-II, or closely related agents are associated with MS. A concomitant review of the current literature supports this view.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848687     DOI: 10.1212/wnl.41.3.335

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis.

Authors:  H Perron; J A Garson; F Bedin; F Beseme; G Paranhos-Baccala; F Komurian-Pradel; F Mallet; P W Tuke; C Voisset; J L Blond; B Lalande; J M Seigneurin; B Mandrand
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Isolation and growth of a cytopathic agent from multiple sclerosis brain tissue.

Authors:  Anthony R White; Nichole S Dutton; Robert D Cook
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

3.  Human spumaretrovirus antibody reactivity in multiple sclerosis.

Authors:  J Lycke; B Svennerholm; A Svenningsson; W Muranyi; R M Flügel; O Andersen
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

4.  Search for retrovirus in the chronic fatigue syndrome.

Authors:  J W Gow; K Simpson; A Schliephake; W M Behan; L J Morrison; H Cavanagh; A Rethwilm; P O Behan
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

5.  Human coronavirus gene expression in the brains of multiple sclerosis patients.

Authors:  J N Stewart; S Mounir; P J Talbot
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

6.  Detection of coronavirus RNA and antigen in multiple sclerosis brain.

Authors:  R S Murray; B Brown; D Brian; G F Cabirac
Journal:  Ann Neurol       Date:  1992-05       Impact factor: 10.422

7.  Human retrovirus and multiple sclerosis.

Authors:  J P Antel; N R Cashman
Journal:  Mayo Clin Proc       Date:  1991-07       Impact factor: 7.616

Review 8.  Infectious causes of multiple sclerosis.

Authors:  Donald H Gilden
Journal:  Lancet Neurol       Date:  2005-03       Impact factor: 44.182

Review 9.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

Review 10.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.